Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 198

1.

The HeLa cell receptor for enterovirus 70 is decay-accelerating factor (CD55).

Karnauchow TM, Tolson DL, Harrison BA, Altman E, Lublin DM, Dimock K.

J Virol. 1996 Aug;70(8):5143-52.

PMID:
8764022
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Short consensus repeat domain 1 of decay-accelerating factor is required for enterovirus 70 binding.

Karnauchow TM, Dawe S, Lublin DM, Dimock K.

J Virol. 1998 Nov;72(11):9380-3.

PMID:
9765493
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses.

Bergelson JM, Chan M, Solomon KR, St John NF, Lin H, Finberg RW.

Proc Natl Acad Sci U S A. 1994 Jun 21;91(13):6245-8.

PMID:
7517044
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Coxsackie B viruses that use human DAF as a receptor infect pig cells via pig CAR and do not use pig DAF.

Spiller OB, Goodfellow IG, Evans DJ, Hinchliffe SJ, Morgan BP.

J Gen Virol. 2002 Jan;83(Pt 1):45-52.

PMID:
11752699
[PubMed - indexed for MEDLINE]
Free Article
5.

Binding to decay-accelerating factor is not required for infection of human leukocyte cell lines by enterovirus 70.

Haddad A, Nokhbeh MR, Alexander DA, Dawe SJ, Grisé C, Gulzar N, Dimock K.

J Virol. 2004 Mar;78(6):2674-81.

PMID:
14990687
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Coxsackievirus A21 binds to decay-accelerating factor but requires intercellular adhesion molecule 1 for cell entry.

Shafren DR, Dorahy DJ, Ingham RA, Burns GF, Barry RD.

J Virol. 1997 Jun;71(6):4736-43.

PMID:
9151867
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Cardiovirulent coxsackieviruses and the decay-accelerating factor (CD55) receptor.

Martino TA, Petric M, Brown M, Aitken K, Gauntt CJ, Richardson CD, Chow LH, Liu PP.

Virology. 1998 May 10;244(2):302-14.

PMID:
9601501
[PubMed - indexed for MEDLINE]
Free Article
8.

Antibody binding to individual short consensus repeats of decay-accelerating factor enhances enterovirus cell attachment and infectivity.

Shafren DR, Dorahy DJ, Thorne RF, Kinoshita T, Barry RD, Burns GF.

J Immunol. 1998 Mar 1;160(5):2318-23.

PMID:
9498772
[PubMed - indexed for MEDLINE]
Free Article
9.

Characterization of echoviruses that bind decay accelerating factor (CD55): evidence that some haemagglutinating strains use more than one cellular receptor.

Powell RM, Schmitt V, Ward T, Goodfellow I, Evans DJ, Almond JW.

J Gen Virol. 1998 Jul;79 ( Pt 7):1707-13.

PMID:
9680134
[PubMed - indexed for MEDLINE]
Free Article
10.

Sialic acid functions in enterovirus 70 binding and infection.

Alexander DA, Dimock K.

J Virol. 2002 Nov;76(22):11265-72.

PMID:
12388686
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55).

Bergelson JM, Mohanty JG, Crowell RL, St John NF, Lublin DM, Finberg RW.

J Virol. 1995 Mar;69(3):1903-6.

PMID:
7531780
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Enterovirus 70 receptor utilization is controlled by capsid residues that also regulate host range and cytopathogenicity.

Kim MS, Racaniello VR.

J Virol. 2007 Aug;81(16):8648-55. Epub 2007 May 30.

PMID:
17537857
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Characterization of mouse DAF on transfectant cells using monoclonal antibodies which recognize different epitopes.

Ohta R, Imai M, Fukuoka Y, Miwa T, Okada N, Okada H.

Microbiol Immunol. 1999;43(11):1045-56.

PMID:
10609614
[PubMed - indexed for MEDLINE]
14.

Comparative analysis of virus-host cell interactions of haemagglutinating and non-haemagglutinating strains of coxsackievirus B3.

Pasch A, Küpper JH, Wolde A, Kandolf R, Selinka HC.

J Gen Virol. 1999 Dec;80 ( Pt 12):3153-8.

PMID:
10567646
[PubMed - indexed for MEDLINE]
Free Article
15.

Characterization of the echovirus 7 receptor: domains of CD55 critical for virus binding.

Clarkson NA, Kaufman R, Lublin DM, Ward T, Pipkin PA, Minor PD, Evans DJ, Almond JW.

J Virol. 1995 Sep;69(9):5497-501.

PMID:
7543583
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Mapping the binding domains on decay accelerating factor (DAF) for haemagglutinating enteroviruses: implications for the evolution of a DAF-binding phenotype.

Powell RM, Ward T, Goodfellow I, Almond JW, Evans DJ.

J Gen Virol. 1999 Dec;80 ( Pt 12):3145-52.

PMID:
10567645
[PubMed - indexed for MEDLINE]
Free Article
17.

Echoviruses and coxsackie B viruses that use human decay-accelerating factor (DAF) as a receptor do not bind the rodent analogues of DAF.

Spiller OB, Goodfellow IG, Evans DJ, Almond JW, Morgan BP.

J Infect Dis. 2000 Jan;181(1):340-3.

PMID:
10608785
[PubMed - indexed for MEDLINE]
Free Article
18.

Differences in inhibition of replication between Coxsackie B4 virus strains in various cell lines by antibodies to some cell surface proteins.

Frisk G, Jansson K, Ericsson M, Diderholm H.

Virus Res. 2001 Mar;73(2):121-30.

PMID:
11172916
[PubMed - indexed for MEDLINE]
19.

Interaction with coxsackievirus and adenovirus receptor, but not with decay-accelerating factor (DAF), induces A-particle formation in a DAF-binding coxsackievirus B3 isolate.

Milstone AM, Petrella J, Sanchez MD, Mahmud M, Whitbeck JC, Bergelson JM.

J Virol. 2005 Jan;79(1):655-60.

PMID:
15596863
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Enhanced cellular receptor usage by a bioselected variant of coxsackievirus a21.

Johansson ES, Xing L, Cheng RH, Shafren DR.

J Virol. 2004 Nov;78(22):12603-12.

PMID:
15507647
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk